|  
LOGIN HERE [ ]
Remember Me
 
Your Cart (0)
Roche
156 stories
Also Available:
221 video clips
107 still images
Stories per page:
      Page  1  of  18    next page 
Image
Avastin Shows Longest Overall Survival for Patients with Adenocarcinoma, the Most Common Type of Advanced Lung Cancer [Source:Roche Pharmaceuticals]
This update outlines data from a preplanned analysis of the pivotal E4599 study in patients with non-small... More 
  (3)
Image
Tarceva Approved in the EU for Maintenance Use in Advanced Lung Cancer [Source:Roche Pharmaceuticals]
The European Commission has approved Tarceva® (erlotinib) as monotherapy for maintenance treatment in... More 
  (8)
Image
Roche Posts Good Half Year Results [Source:Roche Pharmaceuticals]
The Roche Group posted strong operating results in the first half of 2010. Group sales grew by 5% in local... More 
  (11)
Image
New Video Available: Avastin-Based Therapy Extends Survival Beyond Fourteen Months in Patients with Advanced Lung Cancer, Study ... [Source:Roche Pharmaceuticals]
New data show that Avastin® (bevacizumab) based therapy provides a median overall survival (OS) of 14.6... More 
  (7)
Image
RoACTEMRA: New Hope for Children with Systemic Juvenile Idiopathic Arthritis [Source:Roche Pharmaceuticals]
Roche announced that new data being presented at the EULAR congress demonstrates that RoACTEMRA is highly... More 
  (1)
  (4)
Image
Rheumatoid Arthritis Patients Treated with Roche's MabThera Experience Significant Improvement When Treated Every Six Months [Source:Roche Pharmaceuticals]
Experts at this year's European League Against Rheumatism (EULAR) annual congress highlighted to... More 
  (4)
  (7)
Image
Tarceva Helps Patients with Genetically Distinct Form of Lung Cancer Live Longer [Source:Roche Pharmaceuticals]
Roche announces that new data show that first-line treatment with Tarceva (erlotinib) delivered... More 
  (8)
Image
Avastin-Based Regimen Helps Women with Advanced Ovarian Cancer Live Longer Without Their Disease Worsening, Study Shows [Source:Roche Pharmaceuticals]
Phase III study of Avastin showed women with previously untreated advanced ovarian cancer who received... More 
  (9)
Image
'Maintenance Therapy' with Rituximab (MabThera®) Halves Risk of UK's Fifth Most Common Cancer Progression [Source:Roche Pharmaceuticals]
Targeted antibody therapy MabThera (rituximab) halves the risk of disease progression in previously... More 
  (4)
      Page  1  of  18    next page